Journal
AIDS RESEARCH AND THERAPY
Volume 15, Issue -, Pages -Publisher
BMC
DOI: 10.1186/s12981-018-0194-y
Keywords
HIV; Innate immunity; Monocytes; Natural killer cells; Innate lymphoid cells; Antiretroviral therapy
Categories
Funding
- DELTAS Africa Initiative [107743/Z/15/Z]
- New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency)
- Wellcome Trust [107743/Z/15/Z]
- UK government
- Wellcome Trust [107743/Z/15/Z] Funding Source: Wellcome Trust
Ask authors/readers for more resources
HIV infection causes upregulation of markers of inflammation, immune activation and apoptosis of host adaptive, and innate immune cells particularly monocytes, natural killer (NK) and innate lymphoid cells (ILCs). Although antiretro-viral therapy (ART) restores CD4 T-cell counts, the persistent aberrant activation of monocytes, NK and ILCs observed likely contributes to the incomplete recovery of T-cell effector functions. A better understanding of the effects of HIV infection and ART on the phenotype and function of circulating monocytes, NK, and ILCs is required to guide development of novel therapeutic interventions to optimize immune recovery.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available